facebook

When Does an Eye Freckle Need Biopsy or Treatment Instead of Observation?

3 min read

Most ocular “freckles” are safer to monitor than to remove. Intervention becomes appropriate when objective thresholds are crossed, typically when a lesion shows suspicious change, has high-risk clinical features, or causes diagnostic uncertainty that cannot be resolved with imaging alone. ³

For conjunctival lesions, biopsy/treatment is more common than for intraocular lesions because tissue can be obtained directly. Features that lower the threshold for excision include:

  • Nodularity or thickening
  • New feeder vessels
  • Rapid enlargement or colour change
  • Atypical sites (fornix, tarsal conjunctiva, caruncle)
  • A flat, patchy adult-onset pattern suggestive of primary acquired melanosis (PAM) ²

For PAM, histology (presence and grade of atypia) and extent guide management. Diffuse disease may require excision with cryotherapy and/or topical chemotherapy under specialist care. ¹ ²

For choroidal tumours, biopsy is less common; decisions are usually imaging-based. When multiple validated risk factors accumulate, early referral and definitive treatment may be recommended rather than prolonged observation. ³

References

  1. Wong JR, Nanji AA, Galor A, Karp CL. Management of conjunctival melanoma and primary acquired melanosis. Clinical Ophthalmology. 2014;8:197-206. doi:10.2147/OPTH.S45987. PMID: 25580155.
  2. Shields JA, Shields CL, Mashayekhi A, Marr BP, Benavides R, Thangappan A, et al. Primary acquired melanosis of the conjunctiva: experience with 311 eyes. Ophthalmology. 2008;115(3):511-519.e2. doi:10.1016/j.ophtha.2007.07.003. PMID: 17884168.
  3. Shields CL, Demirci H, Materin MA, Marr BP, Mashayekhi A, Shields JA. Clinical factors in the identification of small choroidal melanoma. Canadian Journal of Ophthalmology. 2004;39(4):351-357. doi:10.1016/S0008-4182(04)80005-X. PMID: 15327099.

Related Topics

About Blue Fin Vision®

Blue Fin Vision® is a GMC-registered, consultant-led ophthalmology clinic with CQC-regulated facilities across London, Hertfordshire, and Essex. Patient outcomes are independently audited by the National Ophthalmology Database, confirming exceptionally low complication rates.